Page 58 - Orange Book Cumulative Supplement 10 October 2012
P. 58
RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012 1-48
CAPSULE; ORAL
FENOFIBRATE (MICRONIZED)
AB DR REDDYS LABS SA 43MG A090859 001 Mar 01, 2012 Feb NEWA
AB 130MG A090859 002 Mar 01, 2012 Feb NEWA
>A> AB MYLAN PHARMS INC 67MG A202676 001 Oct 23, 2012 Oct NEWA
>A> AB 134MG A202676 002 Oct 23, 2012 Oct NEWA
>A> AB 200MG A202676 003 Oct 23, 2012 Oct NEWA
TABLET; ORAL
FENOFIBRATE
AB IMPAX LABS 160MG A076509 002 Mar 26, 2008 May CRLD
AB + 160MG A076509 002 Mar 26, 2008 Mar CRLD
AB TEVA 54MG A076433 001 May 13, 2005 May CMFD
@ 54MG A076433 001 May 13, 2005 Mar DISC
AB + 160MG A076433 002 May 13, 2005 May CMFD
@ 160MG A076433 002 May 13, 2005 Mar DISC
AB VALEANT INTL 48MG A090715 001 Apr 05, 2012 Mar NEWA
AB 145MG A090715 002 Apr 05, 2012 Mar NEWA
FENOPROFEN CALCIUM
CAPSULE; ORAL
NALFON
+ XSPIRE EQ 200MG BASE N017604 003 Aug CAHN
@ EQ 300MG BASE N017604 002 Aug CAHN
EQ 400MG BASE N017604 004 Jul 21, 2009 Aug CAHN
FENTANYL
FILM, EXTENDED RELEASE; TRANSDERMAL
FENTANYL-100
AB AVEVA 100MCG/HR A077449 004 Oct 20, 2008 Jun CAHN
FENTANYL-25
AB AVEVA 25MCG/HR A077449 001 Oct 20, 2008 Jun CAHN
FENTANYL-50
AB AVEVA 50MCG/HR A077449 002 Oct 20, 2008 Jun CAHN
FENTANYL-75
AB AVEVA 75MCG/HR A077449 003 Oct 20, 2008 Jun CAHN
SPRAY; SUBLINGUAL
SUBSYS
INSYS THERAP 0.1MG N202788 001 Jan 04, 2012 Mar CPOT
0.1MCG N202788 001 Jan 04, 2012 Jan NEWA
0.2MG N202788 002 Jan 04, 2012 Mar CPOT
0.2MCG N202788 002 Jan 04, 2012 Jan NEWA
+ 0.4MG N202788 003 Jan 04, 2012 Mar CPOT
+ 0.4MCG N202788 003 Jan 04, 2012 Jan NEWA
0.6MG N202788 004 Jan 04, 2012 Mar CPOT
0.6MCG N202788 004 Jan 04, 2012 Jan NEWA
0.8MG N202788 005 Jan 04, 2012 Mar CPOT
0.8MCG N202788 005 Jan 04, 2012 Jan NEWA
FENTANYL CITRATE
SPRAY, METERED; NASAL
LAZANDA
ARCHIMEDES EQ 0.1MG BASE N022569 001 Jun 30, 2011 Jan CPOT
+ EQ 0.4MG BASE N022569 002 Jun 30, 2011 Jan CPOT
TROCHE/LOZENGE; TRANSMUCOSAL
FENTANYL CITRATE
AB PAR PHARM EQ 0.2MG BASE A077312 001 Oct 30, 2009 Feb CAHN